LeonaBio, Inc. Common Stock (LONA) is a publicly traded the market company. As of November 16, 2026, LONA trades at $3.26 with a market cap of $32.69M and a P/E ratio of 0.00. LONA moved -6.34% today. Year to date, LONA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $2.21 to $14.21. Analyst consensus is strong buy with an average price target of $16.67. Rallies surfaces LONA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LeonaBio Q3 net loss more than triples to $21.16 million: LeonaBio’s third-quarter 2026 net loss more than tripled year over year to $21.16 million, while cash, cash equivalents and investments fell 63% to $32.3 million at September 30.
| Metric | Value |
|---|---|
| Price | $3.26 |
| Market Cap | $32.69M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.21 |
| 52-Week Low | $2.21 |
| Volume | 57.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover LONA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.67.